11 September 2020 in The Natural Products Journal
Background: The current research aimed to explore secondary metabolites and antibacterial activity against bacterial agents associated with bovine mastitis from extracts prepared from the peel of fruits of Punica granatum L.. Mastitis is an inflammation in the mammary gland mainly due to infection of bacteria and can be presented clinically or subclinically. The infectious bovine mastitis disease is associated with the reduction and changes in the composition of the milk, as well as in the early disposal of the animal. Objective: We describe the bactericidal activity of ethanolic extracts of the fruit peel of P. granatum, against etiological agents of bovine mastitis (Escherichia coli, Staphylococcus aureus and Streptococcus agalactiae). Method: The bactericidal activity was evaluated according to the standards of the European Committee for Antimicrobial Susceptibility Testing and by the broth microdilution methodology according to the standards of the Clinical and Laboratory Standards Institute. The fruit peel extracts of P. granatum were prepared with ethanol solvent (90%). Results: The best results of total inhibition of bacterial growth of the three strains tested were obtained with the concentrations of 75mg/mL of the extract after 1 and 3 hours of treatment. Cell membrane integrity analysis by flow cytometry showed that 1 h of contact there was loss of integrity of the wall and cell membranes. Conclusion: We can suggest that the ethanolic extract of the fruit peel of P. granatum can be an important natural coadjutant compound in the treatment of mastitis as well as being used in the formulation of sanitizers.
7 July 2026 in One Health Microbiology & Infection
Antimicrobial resistance has emerged as a major challenge for both human and veterinary health, highlighting the need for novel therapeutic approaches. Bovine mastitis remains one of the most economically significant infectious diseases affecting dairy production worldwide. In this narrative review, we examine current evidence regarding the antibacterial potential of Punica granatum L. (pomegranate) and its major bioactive constituents, particularly punicalagin, against clinically relevant multidrug-resistant bacterial pathogens. Recent studies indicate that pomegranate-derived extracts possess antibacterial activity against several mastitis-associated organisms, including Staphylococcus aureus and Escherichia coli. Experimental evidence suggests that punicalagin may contribute to membrane destabilization, increased membrane permeability, interference with biofilm formation, and modulation of bacterial stress-response pathways, although the relative importance of these mechanisms appears to vary among bacterial species and experimental systems. Several studies have also reported synergistic interactions between pomegranate-derived compounds and conventional antibiotics against selected multidrug-resistant pathogens. Despite these promising findings, the current evidence remains dominated by in vitro investigations, while in vivo efficacy, pharmacokinetic characterization, toxicological assessment, and clinical validation remain limited.